Validation of the Framingham Diabetes Risk Model Using Community-Based KoGES Data
Hye Ah Lee1, Hyesook Park2,3, Young Sun Hong4
1Clinical Trial Center, Ewha Womans University Mokdong Hospital, Seoul, Korea. khyeah@naver.com.
Journal of Korean Medical Science
|February 6, 2024
Summary
The Framingham Diabetes Risk Model (FDRM) shows acceptable diabetes prediction in Koreans but improves significantly with redefined predictors. Further validation of the modified model is recommended for clinical use.
Area of Science:
- Endocrinology
- Preventive Medicine
- Epidemiology
Background:
- The Framingham Diabetes Risk Model (FDRM) has limitations in predicting diabetes risk according to current clinical standards.
- Evaluating the FDRM's validity in the Korean population is crucial due to potential ethnic and clinical variations.
Purpose of the Study:
- Assess the original FDRM's performance in a Korean cohort.
- Develop and validate a modified FDRM incorporating updated predictors and clinical features.
- Enhance diabetes risk prediction accuracy for the Korean population.
Main Methods:
- Utilized a community-based Korean cohort (n=5,409) for an 8-year follow-up study.
- Modified the FDRM by redefining predictors like hypertension and incorporating additional clinical factors.
- Evaluated model performance using Area Under the Curve (AUC) for internal and external validation.
Main Results:
- The modified FDRM, including age, obesity, hypertension, lipid profiles, and glycemic markers, achieved an AUC of 0.82.
- An expanded model with additional clinical features showed a slightly higher AUC (0.83) but lacked sustained performance in validation.
- Both modified models demonstrated strong external validity with AUCs exceeding 0.82 in independent datasets.
Conclusions:
- The original FDRM provides acceptable diabetes prediction in Koreans, but significant improvement is achieved with redefined predictors.
- The modified FDRM demonstrates enhanced accuracy and validity for diabetes risk assessment in the Korean population.
- Further evaluation of the modified model's long-term validity and clinical utility is warranted.
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
366
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
366
Bias in Epidemiological Studies
271
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
271
Hazard Ratio
124
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
124
Relative Risk
171
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
171
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Goodness-of-Fit Test
3.3K
The goodness-of-fit test is a type of hypothesis test which determines whether the data "fits" a particular distribution. For example, one may suspect that some anonymous data may fit a binomial distribution. A chi-square test (meaning the distribution for the hypothesis test is chi-square) can be used to determine if there is a fit. The null and alternative hypotheses may be written in sentences or stated as equations or inequalities. The test statistic for a goodness-of-fit test is given as...
3.3K


